T. Wagner

发表论文 8 篇 · 总被引 89 次 · h-index 4

代表论文

• Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody† (2018 · British Journal of Dermatology · 被引 41)
• Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis (2017 · Arthritis Research & Therapy · 被引 33)
• SAT0210 First-in-Patient Study of Namilumab, an Anti-GM-CSF Monoclonal Antibody, in Active Rheumatoid Arthritis: Results of the Priora Phase IB Study (2015 · 被引 7)
• Phase I Dose Escalation Study with the Lewis Y Carbohydrate Specific Humanized Antibody IGN311 (2011 · 被引 6)
• Anti‐GM‐CSF therapy in psoriasis (2019 · British Journal of Dermatology · 被引 1)
• AB0484 An Integrated Pharmacokinetic and Pharmacodynamic Approach to Guide Dose Selection of Namilumab, an Anti-GM-CSF Monoclonal Antibody, for Phase II Rheumatoid Arthritis Studies (2015 · 被引 1)